Vint Cerf speaks on stage at The 23rd Annual Webby Awards on May 13, 2019 in New York City. Noam Galai/Getty Images for Webby Awards Vint Cerf retired from Google on July 7 after 21 years as the ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
This requires an algorithm: students are taught to stack one number atop another and multiply each digit of the bottom number ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
These snakes can go for months without eating, grow and shrink the size of their hearts and jump start their metabolism on a ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results